Loading...
XJPX
7523
Market cap108mUSD
Oct 09, Last price  
1,876.00JPY
1D
-0.05%
1Q
4.57%
Jan 2017
251.31%
Name

Art Vivant Co Ltd

Chart & performance

D1W1MN
XJPX:7523 chart
P/E
10.17
P/S
1.35
EPS
184.40
Div yield, %
5.33%
Shrs. gr., 5y
-2.95%
Rev. gr., 5y
9.96%
Revenues
12.67b
+18.11%
9,449,000,0008,277,000,0006,888,000,0006,509,138,0006,155,375,0005,659,345,0005,332,210,0005,960,010,0005,700,664,0005,929,342,0006,607,315,0007,180,467,0008,168,467,0008,770,192,0007,886,026,00010,253,553,00010,724,889,00011,006,334,00010,731,448,00012,674,953,000
Net income
1.69b
+33.29%
-791,000,000-311,000,00024,000,000-391,665,000-903,069,000-285,446,000647,024,000767,388,000506,179,000532,092,000-599,503,000533,563,0001,945,963,0001,157,352,000428,994,0001,150,260,0001,354,323,0001,766,992,0001,266,065,0001,687,574,000
CFO
3.75b
+86.00%
1,330,000,0002,435,000,0001,441,000,000-1,040,441,000-1,295,588,000499,641,00028,344,000775,835,000-1,075,616,000-824,807,000865,800,0001,046,690,0001,064,031,999-602,029,0001,256,720,000-336,950,000162,666,000-495,555,0002,016,916,0003,751,480,000
Dividend
Mar 30, 202730 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Art Vivant Co., Ltd. operates predominantly within the artistic domain, offering a diverse selection of works. Their inventory includes various forms of paintings, such as reproduced prints, original oil-based creations, and delicate watercolor pieces. Beyond canvases, they also market handcrafted items like sculptures and intricate glass artistry, alongside a range of other art-related goods. The company has further expanded its interests into the wellness and finance industries. Within its financial division, Art Vivant extends various credit solutions. On the wellness front, it oversees the CARNA resort and fitness facility, in addition to Amida, which specializes in lava hot yoga experiences. Established in 1971, Art Vivant Co., Ltd. maintains its headquarters in Tokyo, Japan.

Key people

Katsumi Nozawa
Chairman of the Board, President, Executive Officer, Chairman & President of Subsidiaries, Representative Director · since 2022
Kazuyo Kuzunuki
Executive Officer, General Manager · since 2024
Jun Yamamoto
Executive Officer · since 2025
Koji Higuchi
Executive Officer, Director of Administration, Manager of Business Planning Office, Director · since 2022
Kazuya Iwamoto
Executive Officer, Director · since 2017
Takeshi Nozawa
Executive Officer, President of Subsidiary, Director · since 2022
Masahiro Okamoto
Executive Officer, Director of Art Genes Business, Director · since 2024
Masato Gokura
Independent Director · since 2021
IPO date
Nov 01, 1996
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT